Effects of antiviral therapy on the cellular immune response in acute hepatitis C. - Wikidata - wikimedia - TriplyDB

Effects of antiviral therapy on the cellular immune response in acute hepatitis C.

Effects of antiviral therapy on the cellular immune response in acute hepatitis C.

http://www.wikidata.org/entity/Q42986125

about

First Dominique Dormont International Conference on "Host-pathogen interactions in chronic infections - viral and host determinants of HCV, HCMV, and HIV infections"Replicative homeostasis II: influence of polymerase fidelity on RNA virus quasispecies biology: implications for immune recognition, viral autoimmunity and other "virus receptor" diseases Cellular immune response to hepatitis-C-virus in subjects without viremia or seroconversion: is it important?Immune responses to HCV and other hepatitis viruses Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins.Full-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapy.Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearance Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C High levels of subgenomic HCV plasma RNA in immunosilent infections Heterologous T cell immunity in severe hepatitis C virus infection Acute hepatitis C virus infection: A chronic problem Enhanced IL-10 production in response to hepatitis C virus proteins by peripheral blood mononuclear cells from human immunodeficiency virus-monoinfected individuals Hepatic Transcriptome Analysis of Hepatitis C Virus Infection in Chimpanzees Defines Unique Gene Expression Patterns Associated with Viral Clearance Early Interferon Therapy for Hepatitis C Virus Infection Rescues Polyfunctional, Long-Lived CD8+ Memory T Cells Hepatitis C virus lymphotropism and peculiar immunological phenotype: Effects on natural history and antiviral therapy Hepatitis C Virus (HCV)–Specific Immune Responses of Long‐Term Injection Drug Users Frequently Exposed to HCV Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence Inhibition of Intrahepatic Gamma Interferon Production by Hepatitis C Virus Nonstructural Protein 5A in Transgenic Mice Rate of Sustained Virologic Response in Relation to Baseline Hepatitis C Virus (HCV) RNA Level and Rapid Virologic Clearance in Persons with Acute HCV Infection Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop.Immune response in addicts with chronic hepatitis C treated with interferon and ribavirin.CD8(+) T-Cell Responses in Acute Hepatitis C Virus Infection.Ribavirin improves early responses to peginterferon through improved interferon signaling Comparison of immune restoration in early versus late alpha interferon therapy against hepatitis C virus.Contradictory immune response in post liver transplantation hepatitis B and C.A meta-analysis of the existing knowledge of immunoreactivity against hepatitis C virus (HCV)Ribavirin exerts differential effects on functions of Cd4+ Th1, Th2, and regulatory T cell clones in hepatitis C.Natural Killer Cells in Viral Hepatitis.Escape from a dominant HLA-B*15-restricted CD8+ T cell response against hepatitis C virus requires compensatory mutations outside the epitope.Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence.Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion Ribavirin improves the IFN-γ response of natural killer cells to IFN-based therapy of hepatitis C virus infection.Antigen-specific T lymphocyte proliferation decreases over time in advanced chronic hepatitis C.HCV-HIV coinfection: simple messages from a complex disease.Infectivity in chimpanzees (Pan troglodytes) of plasma collected before HCV RNA detectability by FDA-licensed assays: implications for transfusion safety and HCV infection outcomes Private aspects of heterologous immunity.Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections.Sporadic reappearance of minute amounts of hepatitis C virus RNA after successful therapy stimulates cellular immune responses Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection.

P2860

Q24795522-6740EBAC-B7DF-4507-8719-735D959E45C6 Q24814157-0A38B6F9-361D-48D6-BF7B-735FE6523733 Q26749249-B2E3E935-8CAD-495A-BE1F-D910AAF3E684 Q26866955-51E1C888-3551-4154-81C4-21B27A5EE114 Q27471458-4391CD4D-DDEE-4B98-B223-D463DA14A91E Q27472170-3F9B3418-830F-4C1B-8EEB-AF696919D7C6 Q27477499-E0E89912-90D6-461E-9D0A-211704A10C00 Q27478328-C84A84FE-931E-4B0C-920C-9DD25B109D39 Q27480302-3671FFDB-24F4-4EE7-916C-524DFB2B6635 Q27481224-EF95E0F8-6AA2-4D69-9616-E0AE6AF0E19C Q27485208-1AF1E78D-05D1-4D83-9425-82C30BECC1C6 Q27485639-C84EB589-2322-4307-85BB-42608BD84251 Q27486399-30EC2851-984D-4AC4-B226-778D74CE79D9 Q27487011-ECF49E6B-9BBD-4052-810F-07658A4FE3AA Q27487038-4B8CA064-447B-4F07-B38A-63C79C5A6E8A Q27488413-12E0B307-AB93-4B35-9969-0A8E98ACC20E Q27488816-9CFE6C08-CBD8-42A4-8DBD-BEF9088155B9 Q27488844-2AADD9E2-217D-4739-8DAD-62ABD3E4BA2D Q27489517-F756FDFF-88F3-49B8-8056-512F5B6DF8CE Q27490171-4498686C-E267-491D-B47A-2686D23DBBB2 Q27490650-7660BB70-EEA1-4D2B-8973-77F74E8593AE Q33268083-B3B48D39-CFE1-4AA3-945A-4E0C3A454561 Q33718778-3BD0FDBC-7F12-40C1-8371-D6F66CA8A882 Q33987120-7D73BFD2-0251-4AE2-8E07-4E2645B480CD Q34120848-B263848C-6AE9-4BDD-907A-9F3A7376A4D8 Q34152074-BBB18755-ED17-4956-BEE4-E1A66EA445B2 Q34295420-9FB4E4DE-5E10-4675-BCE4-4A770D469313 Q34359514-2C7E3CBC-C07D-400E-AE17-6180FF7D6F8A Q34505690-DE54AB8D-DCEA-4190-8987-76854F8533F4 Q35665865-609EB873-5625-4781-9A51-8CA72A7883C7 Q35679577-AC21352E-B6DF-4E07-A1AB-865DF44FBD1A Q35741969-636DBFB4-534A-40B4-95C8-A60492FC9802 Q35748913-9847F299-D89B-4179-BE13-232DD57960C8 Q35952291-53F2A502-E76E-4281-A632-A09F813DAF73 Q36026387-BE08A39A-17EF-4F2F-814E-A924985D738E Q36058580-EE4F8011-BAFC-4BE7-8A2C-15AAA18F7EC9 Q36064461-F8F0B1B4-9CDF-41D6-BEC1-775048664F1C Q36073739-7AD56502-C042-4769-B2D2-BFFBB1CFE835 Q36103046-0DC79BA5-C16A-4A6E-8871-545265E3DD6C Q36228011-88789415-7B43-4633-BB43-A159708A988B

P2860

Effects of antiviral therapy on the cellular immune response in acute hepatitis C.

http://www.wikidata.org/entity/Q42986125

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Effects of antiviral therapy on the cellular immune response in acute hepatitis C.

@en

Effects of antiviral therapy on the cellular immune response in acute hepatitis C.

@nl

type

label

Effects of antiviral therapy on the cellular immune response in acute hepatitis C.

@en

Effects of antiviral therapy on the cellular immune response in acute hepatitis C.

@nl

prefLabel

Effects of antiviral therapy on the cellular immune response in acute hepatitis C.

@en

Effects of antiviral therapy on the cellular immune response in acute hepatitis C.

@nl

P1433

Q42986125-E8928375-580E-42D8-ABC3-213E80DCF881

P1476

Q42986125-C98C2947-41F9-4DAF-B3F6-7C73D978AC17

P2093

Q42986125-12BFA1FF-23DD-44F9-942F-C4316209C8A0

Q42986125-18436752-DC18-4460-9BB9-C2BD137A84B1

Q42986125-1F5EC153-BB81-42AB-9244-D593A617AE78

Q42986125-2465544B-CAF2-43BC-A368-9C88473CC6D6

Q42986125-3A8E8019-D5C8-4B42-8DA1-2DEE14F9DC07

Q42986125-3CCA95D1-FB11-4EFA-9AC7-EDEAAACE8C35

Q42986125-5A4749DD-A222-4D4D-B73F-4B144D913678

Q42986125-91B55F52-201E-43D5-9DBE-DB6B47F602C8

Q42986125-F3F3B80A-9994-41CA-A458-0A71921AB902

Q42986125-FA19048F-9306-4B7B-B6C2-AC89CAA0E197

P2860

Q42986125-7C350BD3-51EB-4175-9944-DE87FBFAC8F6

Q42986125-9F5A2E23-6705-4E74-814F-04DC0C6D68F4

P304

Q42986125-417F4908-8BD0-47AE-BC9A-2B5029E1B5E5

P31

Q42986125-1ABA53EF-75FD-45AA-AF27-E6EAFB42CDE3

P356

Q42986125-918EEA40-F8E6-41B1-BB4B-1B4153D178AF

P407

Q42986125-D50FEF07-553F-4B61-AD20-A331665BEB9B

P433

Q42986125-DF5F68CC-93ED-4632-93D5-5B8AA4659D29

P478

Q42986125-B19307F0-7B0E-44F1-83B6-66FFB92CB69E

P577

Q42986125-D5FF9712-6D87-435F-9AA8-631D99251507

P5875

Q42986125-AE5FEC06-AE85-4948-8A5F-9C232D46C1EA

P698

Q42986125-9CA5F001-CC94-4B6D-8714-4308F2202331

P356

P1433

P1476

Effects of antiviral therapy on the cellular immune response in acute hepatitis C.

@en

P2093

Barbara Rehermann

http://www.w3.org/2001/XMLSchema#string

Eishiro Mizukoshi

http://www.w3.org/2001/XMLSchema#string

Fareed Rahman

http://www.w3.org/2001/XMLSchema#string

Harvey Alter

http://www.w3.org/2001/XMLSchema#string

Jay Hoofnagle

http://www.w3.org/2001/XMLSchema#string

Michelina Nascimbeni

http://www.w3.org/2001/XMLSchema#string

Steven Herrine

http://www.w3.org/2001/XMLSchema#string

T Jake Liang

http://www.w3.org/2001/XMLSchema#string

Theo Heller

http://www.w3.org/2001/XMLSchema#string

Yuji Sobao

http://www.w3.org/2001/XMLSchema#string

P2860

Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

P304

87-97

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.20253

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

2004-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8470124

http://www.w3.org/2001/XMLSchema#string

P698

15239090

http://www.w3.org/2001/XMLSchema#string